As the global economy mends, the 2021 growth of Human Lyophilized Rabies Vaccine will have significant change from previous year. According to our (Publisher) latest study, the global Human Lyophilized Rabies Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Lyophilized Rabies Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Human Lyophilized Rabies Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Human Lyophilized Rabies Vaccine market, reaching US$ million by the year 2028. As for the Europe Human Lyophilized Rabies Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Human Lyophilized Rabies Vaccine players cover Bharat Biotech, Sanofi-Pasteur, Serum Institute of India, and Bio-Med, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Lyophilized Rabies Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Pre-Exposure Vaccine
Post-Exposure Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Children
Adults
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bharat Biotech
Sanofi-Pasteur
Serum Institute of India
Bio-Med
Novartis Pharmaceuticals
Bavarian Nordic
Chengdu Kanghua Biological
Changchun Zhuoyi Biological
Liaoning Chengda Biotech
Liaoning Yisheng Biopharma
Beijing Minhai Biological
Shenzhen Weiguang
Ningbo Rongan Biological
Guangzhou Promise Biological
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Lyophilized Rabies Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Lyophilized Rabies Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Lyophilized Rabies Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Human Lyophilized Rabies Vaccine Segment by Type
2.2.1 Pre-Exposure Vaccine
2.2.2 Post-Exposure Vaccine
2.3 Human Lyophilized Rabies Vaccine Sales by Type
2.3.1 Global Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Human Lyophilized Rabies Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Lyophilized Rabies Vaccine Sale Price by Type (2017-2022)
2.4 Human Lyophilized Rabies Vaccine Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Human Lyophilized Rabies Vaccine Sales by Application
2.5.1 Global Human Lyophilized Rabies Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Human Lyophilized Rabies Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Lyophilized Rabies Vaccine Sale Price by Application (2017-2022)
3 Global Human Lyophilized Rabies Vaccine by Company
3.1 Global Human Lyophilized Rabies Vaccine Breakdown Data by Company
3.1.1 Global Human Lyophilized Rabies Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Human Lyophilized Rabies Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Human Lyophilized Rabies Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Human Lyophilized Rabies Vaccine Revenue by Company (2020-2022)
3.2.2 Global Human Lyophilized Rabies Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Human Lyophilized Rabies Vaccine Sale Price by Company
3.4 Key Manufacturers Human Lyophilized Rabies Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Lyophilized Rabies Vaccine Product Location Distribution
3.4.2 Players Human Lyophilized Rabies Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Lyophilized Rabies Vaccine by Geographic Region
4.1 World Historic Human Lyophilized Rabies Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Lyophilized Rabies Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Lyophilized Rabies Vaccine Annual Revenue by Geographic Region
4.2 World Historic Human Lyophilized Rabies Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Human Lyophilized Rabies Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Lyophilized Rabies Vaccine Annual Revenue by Country/Region
4.3 Americas Human Lyophilized Rabies Vaccine Sales Growth
4.4 APAC Human Lyophilized Rabies Vaccine Sales Growth
4.5 Europe Human Lyophilized Rabies Vaccine Sales Growth
4.6 Middle East & Africa Human Lyophilized Rabies Vaccine Sales Growth
5 Americas
5.1 Americas Human Lyophilized Rabies Vaccine Sales by Country
5.1.1 Americas Human Lyophilized Rabies Vaccine Sales by Country (2017-2022)
5.1.2 Americas Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022)
5.2 Americas Human Lyophilized Rabies Vaccine Sales by Type
5.3 Americas Human Lyophilized Rabies Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Lyophilized Rabies Vaccine Sales by Region
6.1.1 APAC Human Lyophilized Rabies Vaccine Sales by Region (2017-2022)
6.1.2 APAC Human Lyophilized Rabies Vaccine Revenue by Region (2017-2022)
6.2 APAC Human Lyophilized Rabies Vaccine Sales by Type
6.3 APAC Human Lyophilized Rabies Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Lyophilized Rabies Vaccine by Country
7.1.1 Europe Human Lyophilized Rabies Vaccine Sales by Country (2017-2022)
7.1.2 Europe Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022)
7.2 Europe Human Lyophilized Rabies Vaccine Sales by Type
7.3 Europe Human Lyophilized Rabies Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Lyophilized Rabies Vaccine by Country
8.1.1 Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Type
8.3 Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Lyophilized Rabies Vaccine
10.3 Manufacturing Process Analysis of Human Lyophilized Rabies Vaccine
10.4 Industry Chain Structure of Human Lyophilized Rabies Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Lyophilized Rabies Vaccine Distributors
11.3 Human Lyophilized Rabies Vaccine Customer
12 World Forecast Review for Human Lyophilized Rabies Vaccine by Geographic Region
12.1 Global Human Lyophilized Rabies Vaccine Market Size Forecast by Region
12.1.1 Global Human Lyophilized Rabies Vaccine Forecast by Region (2023-2028)
12.1.2 Global Human Lyophilized Rabies Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Lyophilized Rabies Vaccine Forecast by Type
12.7 Global Human Lyophilized Rabies Vaccine Forecast by Application
13 Key Players Analysis
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech Human Lyophilized Rabies Vaccine Product Offered
13.1.3 Bharat Biotech Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Sanofi-Pasteur
13.2.1 Sanofi-Pasteur Company Information
13.2.2 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Product Offered
13.2.3 Sanofi-Pasteur Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi-Pasteur Main Business Overview
13.2.5 Sanofi-Pasteur Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Human Lyophilized Rabies Vaccine Product Offered
13.3.3 Serum Institute of India Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 Bio-Med
13.4.1 Bio-Med Company Information
13.4.2 Bio-Med Human Lyophilized Rabies Vaccine Product Offered
13.4.3 Bio-Med Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bio-Med Main Business Overview
13.4.5 Bio-Med Latest Developments
13.5 Novartis Pharmaceuticals
13.5.1 Novartis Pharmaceuticals Company Information
13.5.2 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Product Offered
13.5.3 Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Pharmaceuticals Main Business Overview
13.5.5 Novartis Pharmaceuticals Latest Developments
13.6 Bavarian Nordic
13.6.1 Bavarian Nordic Company Information
13.6.2 Bavarian Nordic Human Lyophilized Rabies Vaccine Product Offered
13.6.3 Bavarian Nordic Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bavarian Nordic Main Business Overview
13.6.5 Bavarian Nordic Latest Developments
13.7 Chengdu Kanghua Biological
13.7.1 Chengdu Kanghua Biological Company Information
13.7.2 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Product Offered
13.7.3 Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chengdu Kanghua Biological Main Business Overview
13.7.5 Chengdu Kanghua Biological Latest Developments
13.8 Changchun Zhuoyi Biological
13.8.1 Changchun Zhuoyi Biological Company Information
13.8.2 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Product Offered
13.8.3 Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Changchun Zhuoyi Biological Main Business Overview
13.8.5 Changchun Zhuoyi Biological Latest Developments
13.9 Liaoning Chengda Biotech
13.9.1 Liaoning Chengda Biotech Company Information
13.9.2 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Product Offered
13.9.3 Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Liaoning Chengda Biotech Main Business Overview
13.9.5 Liaoning Chengda Biotech Latest Developments
13.10 Liaoning Yisheng Biopharma
13.10.1 Liaoning Yisheng Biopharma Company Information
13.10.2 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Product Offered
13.10.3 Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Liaoning Yisheng Biopharma Main Business Overview
13.10.5 Liaoning Yisheng Biopharma Latest Developments
13.11 Beijing Minhai Biological
13.11.1 Beijing Minhai Biological Company Information
13.11.2 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Product Offered
13.11.3 Beijing Minhai Biological Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Beijing Minhai Biological Main Business Overview
13.11.5 Beijing Minhai Biological Latest Developments
13.12 Shenzhen Weiguang
13.12.1 Shenzhen Weiguang Company Information
13.12.2 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Product Offered
13.12.3 Shenzhen Weiguang Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Shenzhen Weiguang Main Business Overview
13.12.5 Shenzhen Weiguang Latest Developments
13.13 Ningbo Rongan Biological
13.13.1 Ningbo Rongan Biological Company Information
13.13.2 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Product Offered
13.13.3 Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ningbo Rongan Biological Main Business Overview
13.13.5 Ningbo Rongan Biological Latest Developments
13.14 Guangzhou Promise Biological
13.14.1 Guangzhou Promise Biological Company Information
13.14.2 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Product Offered
13.14.3 Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Guangzhou Promise Biological Main Business Overview
13.14.5 Guangzhou Promise Biological Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Human Lyophilized Rabies Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Lyophilized Rabies Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Pre-Exposure Vaccine
Table 4. Major Players of Post-Exposure Vaccine
Table 5. Global Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Human Lyophilized Rabies Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Human Lyophilized Rabies Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Human Lyophilized Rabies Vaccine Revenue by Application (2017-2022)
Table 13. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Human Lyophilized Rabies Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Human Lyophilized Rabies Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Human Lyophilized Rabies Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Human Lyophilized Rabies Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Human Lyophilized Rabies Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Human Lyophilized Rabies Vaccine Producing Area Distribution and Sales Area
Table 21. Players Human Lyophilized Rabies Vaccine Products Offered
Table 22. Human Lyophilized Rabies Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Lyophilized Rabies Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Human Lyophilized Rabies Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Human Lyophilized Rabies Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Human Lyophilized Rabies Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Human Lyophilized Rabies Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Human Lyophilized Rabies Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Human Lyophilized Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Human Lyophilized Rabies Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Human Lyophilized Rabies Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Human Lyophilized Rabies Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Human Lyophilized Rabies Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Human Lyophilized Rabies Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Human Lyophilized Rabies Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Human Lyophilized Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Human Lyophilized Rabies Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Human Lyophilized Rabies Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Human Lyophilized Rabies Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Human Lyophilized Rabies Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Human Lyophilized Rabies Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Human Lyophilized Rabies Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Human Lyophilized Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Human Lyophilized Rabies Vaccine
Table 66. Key Market Challenges & Risks of Human Lyophilized Rabies Vaccine
Table 67. Key Industry Trends of Human Lyophilized Rabies Vaccine
Table 68. Human Lyophilized Rabies Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Human Lyophilized Rabies Vaccine Distributors List
Table 71. Human Lyophilized Rabies Vaccine Customer List
Table 72. Global Human Lyophilized Rabies Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Human Lyophilized Rabies Vaccine Sales Market Forecast by Region
Table 74. Global Human Lyophilized Rabies Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Human Lyophilized Rabies Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Human Lyophilized Rabies Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Human Lyophilized Rabies Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Human Lyophilized Rabies Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Human Lyophilized Rabies Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Human Lyophilized Rabies Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Human Lyophilized Rabies Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Human Lyophilized Rabies Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Human Lyophilized Rabies Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Human Lyophilized Rabies Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Human Lyophilized Rabies Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Human Lyophilized Rabies Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Human Lyophilized Rabies Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Human Lyophilized Rabies Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Human Lyophilized Rabies Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Human Lyophilized Rabies Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Human Lyophilized Rabies Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bharat Biotech Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Bharat Biotech Human Lyophilized Rabies Vaccine Product Offered
Table 94. Bharat Biotech Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Bharat Biotech Main Business
Table 96. Bharat Biotech Latest Developments
Table 97. Sanofi-Pasteur Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi-Pasteur Human Lyophilized Rabies Vaccine Product Offered
Table 99. Sanofi-Pasteur Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi-Pasteur Main Business
Table 101. Sanofi-Pasteur Latest Developments
Table 102. Serum Institute of India Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Serum Institute of India Human Lyophilized Rabies Vaccine Product Offered
Table 104. Serum Institute of India Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Serum Institute of India Main Business
Table 106. Serum Institute of India Latest Developments
Table 107. Bio-Med Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio-Med Human Lyophilized Rabies Vaccine Product Offered
Table 109. Bio-Med Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Bio-Med Main Business
Table 111. Bio-Med Latest Developments
Table 112. Novartis Pharmaceuticals Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Product Offered
Table 114. Novartis Pharmaceuticals Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Novartis Pharmaceuticals Main Business
Table 116. Novartis Pharmaceuticals Latest Developments
Table 117. Bavarian Nordic Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Bavarian Nordic Human Lyophilized Rabies Vaccine Product Offered
Table 119. Bavarian Nordic Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Bavarian Nordic Main Business
Table 121. Bavarian Nordic Latest Developments
Table 122. Chengdu Kanghua Biological Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Product Offered
Table 124. Chengdu Kanghua Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Chengdu Kanghua Biological Main Business
Table 126. Chengdu Kanghua Biological Latest Developments
Table 127. Changchun Zhuoyi Biological Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Product Offered
Table 129. Changchun Zhuoyi Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Changchun Zhuoyi Biological Main Business
Table 131. Changchun Zhuoyi Biological Latest Developments
Table 132. Liaoning Chengda Biotech Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Product Offered
Table 134. Liaoning Chengda Biotech Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Liaoning Chengda Biotech Main Business
Table 136. Liaoning Chengda Biotech Latest Developments
Table 137. Liaoning Yisheng Biopharma Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Product Offered
Table 139. Liaoning Yisheng Biopharma Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Liaoning Yisheng Biopharma Main Business
Table 141. Liaoning Yisheng Biopharma Latest Developments
Table 142. Beijing Minhai Biological Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Beijing Minhai Biological Human Lyophilized Rabies Vaccine Product Offered
Table 144. Beijing Minhai Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Beijing Minhai Biological Main Business
Table 146. Beijing Minhai Biological Latest Developments
Table 147. Shenzhen Weiguang Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Shenzhen Weiguang Human Lyophilized Rabies Vaccine Product Offered
Table 149. Shenzhen Weiguang Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Shenzhen Weiguang Main Business
Table 151. Shenzhen Weiguang Latest Developments
Table 152. Ningbo Rongan Biological Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Product Offered
Table 154. Ningbo Rongan Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Ningbo Rongan Biological Main Business
Table 156. Ningbo Rongan Biological Latest Developments
Table 157. Guangzhou Promise Biological Basic Information, Human Lyophilized Rabies Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Product Offered
Table 159. Guangzhou Promise Biological Human Lyophilized Rabies Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Guangzhou Promise Biological Main Business
Table 161. Guangzhou Promise Biological Latest Developments
List of Figures
Figure 1. Picture of Human Lyophilized Rabies Vaccine
Figure 2. Human Lyophilized Rabies Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Lyophilized Rabies Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Lyophilized Rabies Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Lyophilized Rabies Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Pre-Exposure Vaccine
Figure 10. Product Picture of Post-Exposure Vaccine
Figure 11. Global Human Lyophilized Rabies Vaccine Sales Market Share by Type in 2021
Figure 12. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Human Lyophilized Rabies Vaccine Consumed in Children
Figure 14. Global Human Lyophilized Rabies Vaccine Market: Children (2017-2022) & (K Units)
Figure 15. Human Lyophilized Rabies Vaccine Consumed in Adults
Figure 16. Global Human Lyophilized Rabies Vaccine Market: Adults (2017-2022) & (K Units)
Figure 17. Global Human Lyophilized Rabies Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Application in 2021
Figure 19. Human Lyophilized Rabies Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Human Lyophilized Rabies Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Human Lyophilized Rabies Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Human Lyophilized Rabies Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Human Lyophilized Rabies Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Human Lyophilized Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Human Lyophilized Rabies Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Human Lyophilized Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Human Lyophilized Rabies Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Human Lyophilized Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Human Lyophilized Rabies Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Human Lyophilized Rabies Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Human Lyophilized Rabies Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Human Lyophilized Rabies Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Human Lyophilized Rabies Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Human Lyophilized Rabies Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Human Lyophilized Rabies Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Human Lyophilized Rabies Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Human Lyophilized Rabies Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Human Lyophilized Rabies Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Human Lyophilized Rabies Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Human Lyophilized Rabies Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Human Lyophilized Rabies Vaccine
Figure 63. Industry Chain Structure of Human Lyophilized Rabies Vaccine
Figure 64. Channels of Distr